FDA Submits Proposed Collection of Information for Adverse Event Reporting Guidance

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, focusing on adverse event reporting for outsourcing facilities under the Federal Food, Drug, and Cosmetic Act, Section 503B.